NASDAQ · Biotechnology

Arbutus Biopharma Corporation (ABUS) Stock

$4.18 -2.56% NASDAQ: ABUS Healthcare

Valuation

MetricValue
Price$4.18
Market Cap$825.71M
P/E Ratio5.63
P/B Ratio3.40
P/S Ratio4.84
EPS (TTM)$-0.17
52-Week High$5.45
52-Week Low$3.50
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE90.98%
ROA55.85%
ROCE54.39%
Gross Margin-192.86%
Operating Margin-192.86%
Net Margin84.23%
Debt/Equity0.01
Current Ratio15.67

Annual Financials (USD)

Metric20212022202320242025
Revenue$11.0M$39.0M$18.0M$6.0M$14.0M
Operating Profit$-74.0M$-65.0M$-78.0M$-76.0M$-27.0M
Net Profit$-76.0M$-69.0M$-73.0M$-70.0M$-34.0M
EPS$-0.73$-0.46$-0.44$-0.38$-0.17
Op Margin-669.1%-167.8%-430.5%-1236.7%-192.1%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$204.0M$195.0M$144.0M$132.0M$95.0M
Total Liabilities$35.0M$59.0M$38.0M$34.0M$18.0M
Cash$109.0M$31.0M$26.0M$36.0M$18.0M
Borrowings$19.0M$13.0M$9.0M$6.0M$4.0M

Latest News

ABUS Stock On Track For Best Day In About Two Months — What’s The Moderna Connection? Stocktwits · Jul 16, 2026 Arbutus Biopharma, Genevant sue Pfizer, BioNTech Over Lipid Nanoparticle Patents MT Newswires · Jul 16, 2026 Arbutus Initiates International Patent Infringement Enforcement Actions Against Pfizer and BioNTech, Receives First Payment From Moderna Settlement Agreement and Announces Intent to Return Capital to Shareholders GlobeNewswire · Jul 16, 2026 Arbutus Biopharma (ABUS) Joins Russell Defensive Indexes And Exits Value Benchmarks Simply Wall St. · Jul 9, 2026 ABUS Stock Rallies Ahead Of Big Payout From Moderna Settlement This Week Stocktwits · Jul 7, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-68.0M$-35.0M$-86.0M$-65.0M$-40.0M
Investing Cash Flow$-13.0M$-75.0M$50.0M$23.0M$16.0M
Financing Cash Flow$15.0M$11.0M$1.0M$8.0M$0
Net Cash Flow$57.0M$-79.0M$-4.0M$10.0M$-18.0M
Free Cash Flow$-68.0M$-36.0M$-87.0M$-65.0M$-40.0M

Valuation & Return Ratios

MetricValue
PEG Ratio0.01
EV / EBITDA5.64
FCF Yield-2.80%
Quick Ratio81.42
Interest Coverage1937.05
Return 1Y38.39%
Return 3Y106.94%
Return 5Y73.96%

Ownership

Insiders Held20.46%
Institutions Held71.92%
Institutions Float Held90.42%
Institutional HolderSharesReport Date
Morgan Stanley25,891,4802026-03-31
Two Seas Capital Lp18,557,5432026-03-31
Whitefort Capital Management, LP14,930,8852026-03-31
Blackrock Inc.12,966,9462026-03-31
Vanguard Capital Management LLC6,688,9112026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
ALGSAligos Therapeutics, Inc. $5.31 -0.19% -0.76 $32.86M 0.00%
ALNYAlnylam Pharmaceuticals, Inc. $224.53 +0.05% 36.02 $30.04B 0.00%
ARWRArrowhead Pharmaceuticals, Inc. $60.74 -1.20% -28.66 $8.56B 0.00%
ASMBAssembly Biosciences, Inc. $22.82 -0.57% 40.98 $452.23M 0.00%
AVIRAtea Pharmaceuticals, Inc. $5.16 +2.89% -2.47 $412.54M 0.00%

About Arbutus Biopharma Corporation

Arbutus Biopharma Corporation is led by CEO Lindsay Androski, employs 44 people, headquartered in US, publicly traded since 2007.

Arbutus Biopharma Corporation (ABUS) stock trades at $4.18 with a market capitalization of $825.71M. The stock is valued at a price-to-earnings (P/E) ratio of 5.63, price-to-book of 3.40, price-to-sales of 4.84. Over the past 52 weeks the stock has ranged between $3.50 and $5.45, and currently trades 23.3% below its 52-week high.

On profitability, Arbutus Biopharma Corporation generates a return on equity (ROE) of 90.98% — well above the market average, a sign of a high-quality business, return on capital employed of 54.39%, an operating margin of -192.86%, a net profit margin of 84.23%.

Related Healthcare Stocks

LLY Eli Lilly and Company $1169.93 -1.58% JNJ Johnson & Johnson $256.48 -0.76% ABBV AbbVie Inc. $272.42 +0.39% MRK Merck & Company, Inc. Common Stock (new) $142.40 -0.28% UNH UnitedHealth Group Incorporated Common Stock (DE) $370.95 -1.34% NVS Novartis AG $143.11 -0.12% AZN AstraZeneca PLC $158.78 -0.84% TMO Thermo Fisher Scientific Inc $651.98 -1.52% AMGN Amgen Inc. $407.44 -1.37% GILD Gilead Sciences, Inc. $147.10 +0.17% ABT Abbott Laboratories $98.49 -0.24% NVO Novo Nordisk A/S $38.18 -0.21%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides